Sign in

CIK 0001159036 · Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880488686
Phone
(858) 794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,884,955
in 5 filings, $19.9M under 10b5-1 plans

Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-01 Posard Matthew L. Director Sale 10b5-1 −730 $107.17 $78K 58,109
2026-10-01 Posard Matthew L. Director Sale 10b5-1 −3,300 $108.45 $358K 54,809
2026-10-01 Posard Matthew L. Director Sale 10b5-1 −1,100 $109.57 $121K 53,709
2026-10-01 Posard Matthew L. Director Sale 10b5-1 −100 $110.04 $11K 53,609
2026-09-16 Posard Matthew L. Director Sale 10b5-1 −3,100 $106.13 $329K 74,735
2026-09-16 Posard Matthew L. Director Sale 10b5-1 −3,000 $106.83 $320K 71,735
2026-09-16 Posard Matthew L. Director Sale 10b5-1 −8,896 $108.04 $961K 62,839
2026-09-16 Posard Matthew L. Director Sale 10b5-1 −4,000 $108.99 $436K 58,839
2026-05-05 Posard Matthew L. Director Grant or award +3,796 77,835
2026-05-05 Posard Matthew L. Director Grant or award · Option to Purchase Common Stock +6,040 6,040
2025-05-01 Posard Matthew L. Director Grant or award +4,165 74,039
2025-05-01 Posard Matthew L. Director Grant or award · Option to Purchase Common Stock +5,750 5,750

Page 1 of 1 · 12 trades